Dr. David A. Bellnier joined the staff of Roswell Park Cancer Institute (RPCI) and is currently an Assistant Member (Clinical Research) in the Department of Cell Stress Biology, a member of the Photodynamic Therapy (PDT) Center, a member of the Biophysical Therapies Program and Assistant Professor of Oncology at the State University of New York at Buffalo. Dr. Bellnier earned his doctoral degree in Radiation Biology at SUNY Buffalo, Roswell Park Division, in 1982 and did postdoctoral training in Urology Research at Massachusetts General Hospital in Boston, MA and at the Center for Advanced Laser Research, Baylor University Medical Center in Dallas, TX. Dr. Bellnier’s research focuses primarily on the use of photodynamic therapy, as a monotherapy or in a combination therapy setting, to treat malignant tumors; he also has a large number of collaborations in other fields, including: pharmacologic intervention in moderate-severe burn wounds in rodents; pharmacologic potentiation of local hyperthermia to control solid tumors; pharmacologic protection of normal, and not tumor, tissues following chemoradiation therapy; and the use of PDT to control MRSA. Dr. Bellnier’s research programs take place in the multidisciplinary, highly interactive environments of the PDT Center and the Biophysical Therapies Program, and in collaboration with colleagues throughout the Institute and other Universities/Hospitals.

Photodynamic Therapy: Basic and Translational Research